Jozsef Timar

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Pathology, Molecular Biology
Google:
"Jozsef Timar"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gieszer B, Megyesfalvi Z, Dulai V, et al. (2021) EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study. Translational Lung Cancer Research. 10: 662-674
Nagy N, Reis H, Hadaschik B, et al. (2020) Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology Oncology Research : Por
Timar J, Kashofer K. (2020) Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Reviews
Uhlyarik A, Piurko V, Papai Z, et al. (2020) EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy. Cancers. 12
Baranyi M, Rittler D, Molnár E, et al. (2020) Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo. Pathology Oncology Research : Por
Rittler D, Baranyi M, Molnár E, et al. (2019) The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb. International Journal of Molecular Sciences. 20
Ghimessy AK, Gellert A, Schlegl E, et al. (2019) KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy. Cancers. 11
Molnár E, Garay T, Donia M, et al. (2019) Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression. International Journal of Molecular Sciences. 20
Ladányi A, Tímár J. (2019) Immunologic and immunogenomic aspects of tumor progression. Seminars in Cancer Biology
Doma V, Kárpáti S, Rásó E, et al. (2019) Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma. Bmc Cancer. 19: 786
See more...